Montelukast, the active ingredient in Singulair, has seen its primary patents expire, leading to the availability of generic versions.
When Did Montelukast Patents Expire?
The key patents for montelukast sodium, the active ingredient in Singulair, began to expire around 2012. This marked the beginning of generic competition in the market [1].
How Does Montelukast Work?
Montelukast is a leukotriene receptor antagonist. It works by blocking the action of leukotrienes, which are substances produced by the body that cause inflammation and narrowing of the airways. By inhibiting these effects, montelukast helps to reduce symptoms of asthma and allergic rhinitis [2].
What Conditions Does Montelukast Treat?
Montelukast is prescribed to prevent and control asthma in adults and children. It is also used to relieve the symptoms of allergic rhinitis, such as sneezing, runny nose, nasal congestion, and itching of the nose, throat, or eyes [3].
Who Manufactures Generic Montelukast?
Following the patent expirations, numerous pharmaceutical companies have entered the market with generic versions of montelukast. Companies like Teva Pharmaceuticals, Mylan (now Viatris), and Dr. Reddy's Laboratories are among those producing generic montelukast [4].
How Does Generic Montelukast Compare to Brand-Name Singulair?
Generic montelukast products are required to meet the same standards for quality, safety, and efficacy as the brand-name drug, Singulair. They contain the same active ingredient and are bioequivalent, meaning they are absorbed and act in the body in the same way [1]. The primary difference for consumers is typically cost, with generic versions being significantly less expensive.
What is the Patent Status of Montelukast?
The primary composition of matter patents for montelukast sodium have expired. While some secondary patents related to specific formulations or manufacturing processes may still exist, they generally do not prevent generic entry once the core patent protection has ended [1]. DrugPatentWatch.com tracks patent information for drugs like montelukast [5].
What Are the Potential Side Effects of Montelukast?
Common side effects of montelukast can include headache, stomach pain, and diarrhea. Less common but more serious side effects have been reported, including neuropsychiatric events such as agitation, aggression, depression, and suicidal thoughts. Regulatory agencies have issued warnings regarding these potential risks [6].
Are There Alternatives to Montelukast for Asthma and Allergies?
Yes, there are alternative treatments available for asthma and allergic rhinitis. For asthma, these can include inhaled corticosteroids, long-acting beta-agonists, and other classes of medications depending on the severity and type of asthma. For allergic rhinitis, antihistamines, nasal corticosteroids, and decongestants are common alternatives or adjunct treatments [7].
Sources:
[1] https://www.drugpatentwatch.com/
[2] https://www.ncbi.nlm.nih.gov/books/NBK538204/
[3] https://www.rxlist.com/singulair-drug.htm
[4] https://www.drugs.com/availability/montelukast.html
[5] https://www.drugpatentwatch.com/montelukast-sodium
[6] https://www.fda.gov/drugs/postmarket-drug-safety-information-for-patients-and-providers/montelukast-singulair-information
[7] https://www.aaaai.org/conditions-and-treatments/asthma